|
ABHD14A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.446600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.297500E-03 |
| Normal-vs-Stage2 |
1.790110E-04 |
| Normal-vs-Stage3 |
1.93800000047872E-07 |
| Normal-vs-Stage4 |
4.46330000000161E-05 |
| Stage1-vs-Stage2 |
2.078300E-02 |
| Stage1-vs-Stage3 |
2.551000E-04 |
| Stage1-vs-Stage4 |
4.338800E-03 |
| Stage2-vs-Stage3 |
4.204600E-01 |
| Stage2-vs-Stage4 |
2.736400E-01 |
| Stage3-vs-Stage4 |
5.403800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.657330E-03 |
| Normal-vs-AfricanAmerican |
5.88839999999813E-05 |
| Normal-vs-Asian |
6.432300E-02 |
| Caucasian-vs-AfricanAmerican |
1.719580E-01 |
| Caucasian-vs-Asian |
7.682000E-01 |
| AfricanAmerican-vs-Asian |
8.839000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.184370E-03 |
| Normal-vs-Female |
1.177890E-04 |
| Male-vs-Female |
4.220400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.155320E-04 |
| Normal-vs-Extreme_Weight |
8.826000E-04 |
| Normal-vs-Obese |
1.238780E-03 |
| Normal-vs-Extreme_Obese |
6.726100E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.258160E-01 |
| Normal_Weight-vs-Obese |
4.571600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.966800E-01 |
| Extreme_Weight-vs-Obese |
4.998000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.597200E-01 |
| Obese-vs-Extreme_Obese |
7.231000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.336300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.65699999999225E-05 |
| Normal-vs-Age(61-80Yrs) |
7.016100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.71140999999375E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.064600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.966450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.066000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.492200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.839500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.339600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.326590E-01 |
| Normal-VS-Type2 PRCC |
1.68570046810146E-10 |
| Normal-VS-KIRP CIMP |
1.00039998507384E-09 |
| Normal-VS-Unclassified PRCC |
2.30119999999889E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.24829052544828E-12 |
| Type1 PRCC-VS-KIRP CIMP |
4.60260000112456E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.14070000000133E-05 |
| Type2 PRCC-VS-KIRP CIMP |
1.080410E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.235900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.025800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019750E-04 |
| Normal-vs-N1 |
2.09039999999883E-05 |
| Normal-vs-N2 |
3.263700E-03 |
| N0-vs-N1 |
1.313420E-01 |
| N0-vs-N2 |
1.522200E-01 |
| N1-vs-N2 |
5.393200E-01 |
|
|
